Dr. Marc Hedrick, MD - CEO, Plus Therapeutics - Radiotherapeutics For Difficult-To-Treat CNS Cancers
Dr. Marc Hedrick, MD - CEO, Plus Therapeutics - Radiotherapeutics For Difficult-To-Treat CNS Cancers
4 months ago
rumble.com
Inside the Latest in Targeted Radiotherapeutics with Plus Therapeutics CEO Dr. Marc Hedrick
46:37
Inside the Latest in Targeted Radiotherapeutics with Plus Therapeutics CEO Dr. Marc Hedrick
250 views11 months ago
YouTubePlus Therapeutics, Inc.
This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers. Hear From Plu
8:39
This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers. Hear From Plu
16 viewsApr 4, 2024
DailymotionBenzinga
Plus Therapeutics, Inc. Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for Reyobiq in Leptomeningeal Metastases
Plus Therapeutics, Inc. Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for Reyobiq in Leptomeningeal Metastases
4 months ago
marketscreener.com
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
9:12
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
7 viewsAug 14, 2023
DailymotionBenzinga
Plus Therapeutics-marc Hedrick-benzinga All Access
10:31
Plus Therapeutics-marc Hedrick-benzinga All Access
187 viewsJun 27, 2023
DailymotionBenzinga
About Us - Plus Therapeutics (PSTV)
About Us - Plus Therapeutics (PSTV)
Dec 8, 2021
plustherapeutics.com
Dr. Marc Hedrick, MD - CEO, Plus Therapeutics - Radiotherapeutics For Difficult-To-Treat CNS Cancers
53:46
Dr. Marc Hedrick, MD - CEO, Plus Therapeutics - Radiotherapeutics For Difficult-To-Treat CNS Cancers
13.2K views4 months ago
YouTubeProgress, Potential, and Possibilities
Plus Therapeutics to provide business update on Thursday
Plus Therapeutics to provide business update on Thursday
2 months ago
marketscreener.com
Recurrent Glioblastoma - Plus Therapeutics (PSTV)
Recurrent Glioblastoma - Plus Therapeutics (PSTV)
Dec 5, 2021
plustherapeutics.com
Want To Be A Part Of The Fight Against CNS Cancers?
9:25
Want To Be A Part Of The Fight Against CNS Cancers?
3 viewsMay 16, 2023
DailymotionBenzinga
My key insight from Plus Therapeutics' 2025 Annual Report
10:39
My key insight from Plus Therapeutics' 2025 Annual Report
6 views2 weeks ago
YouTubeCorporate Decoder
Plus Therapeutics (NASDAQ: PSTV) Interview at the NYSE | Fintech TV Exclusive
9:21
Plus Therapeutics (NASDAQ: PSTV) Interview at the NYSE | Fintech TV Exclusive
82.9K views6 months ago
YouTubePlus Therapeutics, Inc.
My Key Insight from Plus Therapeutics' Latest SEC Filing
7:45
My Key Insight from Plus Therapeutics' Latest SEC Filing
9 views2 weeks ago
YouTubeCorporate Decoder
Plus Therapeutics Rhenium NanoLiposome: Investigational Radiotherapy for Recurrent Glioblastoma
2:58
Plus Therapeutics Rhenium NanoLiposome: Investigational Radiotherapy for Recurrent Glioblastoma
15.9K viewsNov 18, 2020
YouTubePlus Therapeutics, Inc.
San Diego startups lead AI-driven drug discovery. BrainStorm wins NVIDIA award. | Neal Bloom🎩 posted on the topic | LinkedIn
San Diego startups lead AI-driven drug discovery. BrainStorm wins NVIDIA award. | Neal Bloom🎩 posted on the topic | LinkedIn
4 months ago
linkedin.com
Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases
1:03:51
Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases
316 viewsAug 21, 2024
YouTubePlus Therapeutics, Inc.
Company - Intensity Therapeutics
Company - Intensity Therapeutics
Apr 28, 2023
intensitytherapeutics.com
Plus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
0:38
Plus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial Update
73 viewsNov 18, 2020
YouTubePlus Therapeutics, Inc.
Plus Therapeutics' ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
2:47
Plus Therapeutics' ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
36.7K viewsApr 25, 2023
YouTubePlus Therapeutics, Inc.
My Key Takeaway from PLUS THERAPEUTICS' Board Nominations
4:45
My Key Takeaway from PLUS THERAPEUTICS' Board Nominations
2 weeks ago
YouTubeCorporate Decoder
Companies To Watch: Pulse Therapeutics
Companies To Watch: Pulse Therapeutics
Jul 10, 2015
meddeviceonline.com
Nano Cap Podcast | Marc Hedrick, MD - Plus Therapeutics, Inc. (Nasdaq: PSTV)
30:16
Nano Cap Podcast | Marc Hedrick, MD - Plus Therapeutics, Inc. (Nasdaq: PSTV)
460 viewsMar 25, 2025
YouTubePlus Therapeutics, Inc.
Plus Therapeutics 8-K: My Take on the Nasdaq Lifeline
5:14
Plus Therapeutics 8-K: My Take on the Nasdaq Lifeline
65 views4 months ago
YouTubeCorporate Decoder
"Glioblastoma A.K.A. GBM" Podcast with Plus Therapeutics
35:10
"Glioblastoma A.K.A. GBM" Podcast with Plus Therapeutics
376 views11 months ago
YouTubePlus Therapeutics, Inc.
EV Therapeutics - Extracellular Vesicle-based Immunotherapy
EV Therapeutics - Extracellular Vesicle-based Immunotherapy
Dec 29, 2020
evtherapeutics.com
플러스 테라퓨틱스 PLUS THERAPEUTICS INC (PSTV)기업 분석
9:20
플러스 테라퓨틱스 PLUS THERAPEUTICS INC (PSTV)기업 분석
912 views6 months ago
YouTube모여라 서학개미
CNSide® Secures Major Payor Coverage | Plus Therapeutics (NASDAQ: PSTV) at NYSE with StockTwits
12:20
CNSide® Secures Major Payor Coverage | Plus Therapeutics (NASDAQ: PSTV) at NYSE with StockTwits
109.6K views4 months ago
YouTubePlus Therapeutics, Inc.
Plus Therapeutics CEO Dr. Marc Hedrick - Cancer's Hardest Problems (Clip)
1:37
Plus Therapeutics CEO Dr. Marc Hedrick - Cancer's Hardest Problems (Clip)
173 viewsDec 21, 2021
YouTubeSeeking Alpha
Expert Insights on Leptomeningeal Metastases
59:48
Expert Insights on Leptomeningeal Metastases
5.6K viewsAug 11, 2023
YouTubePlus Therapeutics, Inc.
See more